Evidence map›Paper›PMID 32812911›Full record

ArticleMetabolism open2020

Isoorientin ameliorates lipid accumulation by regulating fat browning in palmitate-exposed 3T3-L1 adipocytes.

Sithandiwe E Mazibuko-Mbeje, Khanyisani Ziqubu, Phiwayinkosi V Dludla, Luca Tiano, Sonia Silvestri, Patrick Orlando, Thembeka A Nyawo, Johan Louw, Abidemi P Kappo, Christo J F Muller

Open access · goldAbstract read
In one paragraph

Article in Metabolism open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Sithandiwe E Mazibuko-MbejeBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, 7505, South Africa.
Khanyisani ZiqubuBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, 7505, South Africa.
Phiwayinkosi V DludlaBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, 7505, South Africa.
Luca TianoDepartment of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy.
Sonia SilvestriDepartment of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy.
Patrick OrlandoDepartment of Life and Environmental Sciences, Polytechnic University of Marche, Ancona 60131, Italy.
Thembeka A NyawoBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, 7505, South Africa.
Johan LouwBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, 7505, South Africa.
Abidemi P KappoDepartment of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa, 3886, South Africa.
Christo J F MullerBiomedical Research and Innovation Platform, South African Medical Research Council, Tygerberg, 7505, South Africa.
Marche Polytechnic University · ITUniversity of Zululand · ZASouth African Medical Research Council · ZANorth-West University · ZAStellenbosch University · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stimulation of fat browning using natural bioactive products is regarded as one of the promising approaches to treat obesity and insulin resistance. Here, we investigated the physiological effects of isoorientin on glucose uptake and lipid accumulation in insulin resistant 3T3-L1 adipocytes. To achieve this, 3T3-L1 adipocytes were exposed to 0.75 mM palmitate for 24 h, to induce insulin resistance, before treatment with 10 μM isoorientin or the comparative controls such as CL-316,243 (10 μM), pioglitazone (10 μM) and compound C (1 μM) for 4 h. Relevant bioassays and Western blot analysis were conducted on these insulin resistant cells. Our results showed that palmitate exposure could induce insulin resistance and mitochondrial dysfunction as measured by reduction in glucose uptake and impaired mitochondrial bioenergetics parameters. However, treatment with isoorientin reversed these effects by improving glucose uptake, blocking lipid accumulation, and modulating the process of mitochondrial respiration. Mechanistically, isoorientin could mediate lipid metabolism by activating 5' AMP-activated protein kinase (AMPK), while also effectively modulating the expression of genes involved in fat browning such as peroxisome proliferator-activated receptor gamma (PPAR)γ/α and uncoupling protein 1 (UCP1). In conclusion, isoorientin impacts insulin resistance in vitro by improving glucose uptake and mitochondrial function, consistent to modulating the expression of genes involved in energy metabolism and fat browning.

Indexed as

3T3-L1 adipocytesFat browningInsulin resistanceIsoorientinLipid accumulation

Identifiers

PMID32812911
PMCPMC7424791
OpenAlexW3023617507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.